Land: Noorwegen
Taal: Noors
Bron: Statens legemiddelverk
Indium (111In) oksin
Curium Netherlands B.V.
V09HB01
Indium (111In) oxide
37 MBq/ ml
Oppløsning
1 sett
C
Markedsført
1999-11-01
20 APP 4908 Norway SPC 15052019_tc SUMMARY OF PRODUCT CHARACTERISTICS FOR INDIUM (IN-111) OXINATE, RADIOPHARMACEUTICAL PRECURSOR 1. NAME OF THE MEDICINAL PRODUCT Indium (In-111) Oxinate (Curium Netherlands catalogue no.: DRN 4908) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Indium (In-111)chloride 37 MBq (1 mCi) Oxine 0.025 mg 111 In disintegrates by electron capture with a half-life of approximately 67 hours (2.8 days) and emits gamma radiation with principal energies of 172 keV (91 %) and 246 keV (94 %). By internal conversion X radiations of 23 and 26 keV are also emitted. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Radiopharmaceutical precursor. pH = 2.5-3.5. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This medicinal product is for diagnostic use only. Indium ( 111 In) oxine is used as an ingredient for the in-vitro radiolabelling of separated blood cells which are subsequently administered intravenously for a variety of investigative purposes using appropriate imaging/counting procedures. Investigative procedures using indium ( 111 In)-labelled blood cells include: 111 In-labelled leucocytes or granulocytes: Investigation of sites of inflammatory processes and abscesses, complementary with other imaging investigations; for example, localisation of sites of focal infection, such as abdominal abscess, confirmation of bone infection after prosthesis, investigation of pyrexia of unknown origin and evaluation of inflammatory conditions not associated with infection such as inflammatory bowel disease. In red marrow bearing regions of the skeleton, osteomyelitis may present as sites of reduced uptake of 111 In-labelled leucocytes. Diffuse or local pulmonary uptake of 111 In-labelled leucocytes should be interpreted with caution, as this can be due to physiological marginal location. 111 In-labelled platelets (thrombocytes): Determination of platelet survival and biodistribution, particularly spleen and liver uptake in cases of thrombocytopenia, 20 APP 4908 Norway SPC 15052 Lees het volledige document